With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

Researchers at EPFL and Lausanne University Hospital (CHUV), led by professors Grégoire Courtine and Jocelyne Bloch, have achieved a major milestone in the treatment of spinal cord injuries (SCI). By ...

Deep Brain Stimulation (DBS) is an advanced neurosurgical therapy that uses controlled electrical signals to manage Parkinson ...

For more than twenty years deep brain stimulation (DBS) is being used in patients with movement disorders, predominantly in refractory Parkinson's disease (PD) followed by dystonia and essential ...

Novel study by researchers at the Rambam Health Care Campus could help 21 million people worldwide suffering from the severe lifelong mental disorder The post In breakthrough, Israeli scientists use ...

The MarketWatch News Department was not involved in the creation of this content. -- Financing led by Genesys Capital with participation from Cleveland Clinic and JobsOhio Ventures -- Genesys Capital ...

New research suggests that paralyzed patients could regain some degree of movement — perhaps even walk again. In a study led by EPFL (Swiss Federal Technology Institute of Lausanne) and Lausanne ...

Medtronic Percept™ DBS therapy is the only sensing-enabled † DBS system available, allowing a physician to use data from a patient’s brain activity to personalize their treatment. Andy says Medtronic ...

Please provide your email address to receive an email when new articles are posted on . Offering asleep or awake DBS aims to provide PD patients choice, impetus for choosing DBS therapy sooner.

MINNEAPOLIS, Minnesota — The U.S. Food and Drug Administration approved a Medtronic deep brain stimulation treatment to treat obsessive compulsive disorder – the first deep brain stimulation treatment ...

CLEVELAND, Jan. 13, 2026 /PRNewswire/ -- Enspire DBS Therapy, Inc. ("Enspire"), a clinical-stage company developing an implantable neuromodulation therapy for post-stroke recovery, today announced ...